Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

Across the recent three months, 4 analysts have shared their insights on Niagen Bioscience NAGE +12.6% + Free Alerts , ...

Ciena Corp (NYSE: CIEN) reported Q2 financial results, beating revenue estimates but missing EPS. Analysts have mixed ratings ...

QuantumScape has logged a -27.6% 52 week change, compared to 11.1% for the S&P 500 QS has an average analyst rating of hold ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...

We're taking a closer look at Verona Pharma today, as the chatter surrounding the stock has increased notably in the last few ...